- Home
- VTSI vs MAIA Comparison
VTSI vs MAIA Comparison
Compare VTSI & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- MAIA
- Stock Information
- Founded
- VTSI 1993
- MAIA 2018
- Country
- VTSI United States
- MAIA United States
- Employees
- VTSI N/A
- MAIA N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VTSI Consumer Discretionary
- MAIA Health Care
- Exchange
- VTSI Nasdaq
- MAIA Nasdaq
- Market Cap
- VTSI 67.3M
- MAIA 56.3M
- IPO Year
- VTSI N/A
- MAIA 2022
- Fundamental
- Price
- VTSI $6.05
- MAIA $1.71
- Analyst Decision
- VTSI Strong Buy
- MAIA
- Analyst Count
- VTSI 1
- MAIA 0
- Target Price
- VTSI $7.00
- MAIA N/A
- AVG Volume (30 Days)
- VTSI 164.4K
- MAIA 540.2K
- Earning Date
- VTSI 08-11-2025
- MAIA 08-08-2025
- Dividend Yield
- VTSI N/A
- MAIA N/A
- EPS Growth
- VTSI N/A
- MAIA N/A
- EPS
- VTSI 0.19
- MAIA N/A
- Revenue
- VTSI $26,164,645.00
- MAIA N/A
- Revenue This Year
- VTSI $9.92
- MAIA N/A
- Revenue Next Year
- VTSI $16.54
- MAIA N/A
- P/E Ratio
- VTSI $32.08
- MAIA N/A
- Revenue Growth
- VTSI N/A
- MAIA N/A
- 52 Week Low
- VTSI $3.57
- MAIA $1.40
- 52 Week High
- VTSI $9.40
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- VTSI 44.60
- MAIA 43.93
- Support Level
- VTSI $6.40
- MAIA $1.80
- Resistance Level
- VTSI $6.49
- MAIA $2.15
- Average True Range (ATR)
- VTSI 0.43
- MAIA 0.12
- MACD
- VTSI -0.09
- MAIA -0.01
- Stochastic Oscillator
- VTSI 6.77
- MAIA 20.91
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.